{
  "id": 21288398,
  "title": "BUSINESS REFLECTION: Crossed Wires: GLP-1s — the tangled world of weight loss, stigma, addiction and money",
  "url": "https://urgent.news/2026/11/22/business-reflection-crossed-wires-glp-1s-the-tangled-world-of-weight",
  "topic": "world",
  "section": "World",
  "published": "2026-11-22T21:24:51.000Z",
  "source": {
    "name": "Daily Maverick",
    "slug": "daily-maverick",
    "url": "https://www.dailymaverick.co.za/article/2026-11-22-crossed-wires-glp-1s-the-tangled-world-of-weight-loss-stigma-addiction-and-money/"
  },
  "original_language": "en",
  "account": "GLP-1 drugs offer transformative weight-loss and health benefits, but their use is complicated by stigma, regaining weight, high costs, and insurers' short-term thinking. The drugs, originally developed for diabetes treatment, were approved for weight loss in 2014 and 2021. While the drugs are not physically addictive, they can have a psychological addictive component, leading to rapid weight regain after stopping treatment. GLP-1s dampen addictive behaviors and the urge to eat, but users often regain weight within a year, making them an ongoing treatment rather than a cure. Side effects are mostly digestive and temporary, with no significant long-term harm for most users. However, these drugs remain expensive, with monthly costs ranging from $150 to $199, making them inaccessible for many, particularly outside wealthy countries. Insurers, driven by short-term thinking, have not yet started covering these \"miracle\" weight-loss drugs, leaving patients to bear the financial burden.",
  "summary": "GLP-1 drugs promise transformative weight-loss and broader health benefits, but stigma, regaining of weight, high costs and insurers’ short-term thinking complicate their use.",
  "key_points": [
    "GLP-1 drugs revolutionize weight loss and health, approved since 2014 and 2021",
    "Psychological addiction risk leads to rapid weight regain post-treatment",
    "Monthly costs $150-$199 make drugs inaccessible for many outside wealthy nations"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}